190 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
SCIENTIFIC PROGRAMME
182
002
Clinical descriptions and diagnostic guidelines
for substance use disorders in ICD-11
John Saunders, Australia
OS-42
Oral Presentation Session
10:00– 11:30
|
Room R4
TOPIC 1:
Neurocognitive disorders, organic mental
disorders, dementia
Neurocognitive functioning and comorbidity
Chairs:
Lutz Frölich, Germany
Cecile Hanon, France
001
Cognitive functions and quality of life in HIV
seropositive individuals
Aparna Ramakrishnan, India
Krishnamurthy Kavirayani
002
Drug interactions in community-dwelling
people screened positive for dementia: results
of the DelpHi study
René Thyrian, Germany
Diana Wucherer, Johannes Hertel, Bernhard
Michalowsky, Ina Zwingmann, Wolfgang Hoffmann
003
Neurocognitive disorder in patients depending
on the type of consumable opiates
Faniya Shigakova, Uzbekistan
004
Correlates of preserved cognitive functioning
in the oldest-old: a combined PET and MRI study
Paul G. Unschuld, Switzerland
Jiri Van Bergen, Frances C. Quevenco, Anton F. Gietl,
Sandra Leh, Valerie Treyer, Alfred Buck, Roger M. Nitsch,
Christoph Hock
005
Are anxiety disorders associated with accelerated
aging and cognitive decline?
Daniela Caldirola, Italy
Nunzia Valentina Di Chiaro, Adele Ferro, Paolo
Brambilla, Giampaolo Perna
006
Foreign accent syndrome: from neurology to
psychiatry
German Montero Hernandez, Spain
I. Alberdi Páramo, L. Niell Galmés, R. A. Baena Mures,
J. Rodríguez Quijano
OS-43
Oral Presentation Session
10:00– 11:30
|
Room R5
TOPIC 2:
Mental disorders due to psychotropic
substances, behavioural addictions
Addictive disorders
Chairs:
Ursula Havemann-Reinecke, Germany
Nikos Christodoulou, United Kingdom
001
Acute effects of cortisol on alcohol craving in
alcohol use disorder
Leila Maria Soravia, Switzerland
Dominique de Quervain
002
A naturalistic study of predictors of retention
in treatment among emerging adults entering first
buprenorphine maintenance treatment for opioid
dependence
Prabhoo Dayal, India
Yatan Pal Singh Balhara
003
Buprenorphine dependency in a sample of
Tunisian patients: socio demographic and clinical
characteristics
Uta Ouali, Tunisia
Feriel El Ghali, Olfa Meziou, Ghaya Jmii, Molka Zghal,
Haifa Zalila, Fethi Nacef
004
Cost-benefit analysis of the opiate substitution
treatment with buprenorphine/naloxone in Bosnia
and Herzegovina
Mevludin Hasanovic, Bosnia and Herzegovina
Izet Pajevic, Abdurahman Kuldija, Dzenita Hrvic, Senad
Huseinagic
005
Party and play – substance use in sexual con-
text and sexual risk behavior in HIV-positive men,
who have sex with men
Henrike Dirks, Germany
Stefan Esser, Norbert Brockmeyer, Norbert Scherbaum
006
When guards lower the guard: psychoactive
drugs use pattern among medical students
Lamia Jouini, Tunisia
Uta Ouali, Ali Mrabét, Rania Zaouche, Yosra Zgueb,
Jomli Rabaa, Fethi Nacef